Otsuka Holdings Co., Ltd.

Japan

  • 1m
  • 3m
  • 6m
  • 1y
  • 2y
  • 5y
Mar 27, 2017
Prev close: 5,109
Mar 27, 2017
Market cap:
Market cap(USD):
2,849.98B
25,663.95M
Shares: 557.83M

Currency in JPY

Company profile

Market(Ticker): TKS(4578)
Sector:
Industry:
Health Technology
Pharmaceuticals: Other
Full time employees: --

Business summary

Otsuka Holdings Co., Ltd. engages in the manufacturing and sale of pharmaceuticals and nutritional supplements. It operates through the following segments: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others. The Pharmaceuticals segment manufactures therapeutic drugs and infusions focusing on the central nervous system, oncology, and infectious diseases. The Nutraceuticals segment develops and markets nutrition products such as nutritional food, quasi-drugs, health drinks, and dietary supplements for homes, medical facilities, and nursing care units. The Consumer Products segment sells mineral water, food, and beverages. Its products include Bon Curry, Mannan Hikari, and ReSOLA. The Others segment distributes functional and fine chemicals, optical inspection devices, and clinical diagnosis equipment. The company was founded on July 8, 2008 and is headquartered in Tokyo, Japan.

In the news

Financial highlights

Dec 2016

  • Local currency
  • US Dollar
Revenue 1,195.54B
Gross profit 789,216M
Operating income 84,546M
Income before tax 100,706M
Net income 92,563M
EBITDA 144,120M
Diluted EPS 170.7
Dividends per share 100
Total assets 2,478.29B
Total liabilities 739,845M
Total equity 1,710.53B
Operating cash flow 142,004M

Currency in JPY

Revenue 11,002.75M
Gross profit 7,263.24M
Operating income 778.08M
Income before tax 926.80M
Net income 851.86M
EBITDA 1,326.35M
Diluted EPS 1.57
Dividends per share 0.92
Total assets 21,248.25M
Total liabilities 6,343.25M
Total equity 14,665.67M
Operating cash flow 1,306.87M

Currency in USD

Valuation measures

Dec 2016

PER 29.81
ROA 3.64%
ROE 5.50%
Operating margin 7.07%
Profit margin 7.74%

Key executive

  • President, CEO & Representative Director: Tatsuo Higuchi
  • Senior Managing Director & Head-Finance: Atsumasa Makise
  • Managing Director & Head-General Affairs: Yoshiro Matsuo
  • Head-Business Development & Planning: Kuniaki Natsume
  • Auditor: Takaharu Imai

Share holders

  • OTSUKA FAMILY /OTSUKA HOLDINGS/(16.5%)
  • Nomura Asset Management Co., Ltd.(2.8%)
  • Otsuka Holdings Co., Ltd.(2.8%)
  • Otsuka Holdings Employee Stock Ownership Plan(2.5%)
  • The Awa Bank Ltd.(1.9%)
  • The Vanguard Group, Inc.(1.5%)
  • BlackRock Fund Advisors(1.3%)
  • Daiwa Asset Management Co. Ltd.(1.2%)
  • Nikko Asset Management Co., Ltd.(1.2%)
  • Medipal Holdings Corp.(1.1%)

Address

  • Website: http://www.otsuka.com
  • Address: Shinagawa Grand Central Tower, 12/F, 2-16-4 Konan, Tokyo, 108-8241, Japan
  • Phone: +81.3.6717.1410

Copyright © 2017 FactSet Research Systems Inc. All rights reserved.